Showing results (291-300 of 315) with videos related to

Sort By:
Pageof 32
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patientsJ-Y Blay, P Soibinet, N Penel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2012
Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCEJ Thariat, T Schouman, A Brouchet, et al.
Gynecologic Oncology|March 6, 2020
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group StudyC Lenck, N Chopin, S Gouy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2023
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trialI Ray-Coquard, A Leary, S Pignata, et al.
The Indian Journal of Medical Research|September 11, 2015
Efficacy of stem cell in improvement of left ventricular function in acute myocardial infarction--MI3 TrialVelu Nair, Hemant Madan, Sunil Sofat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2025
Dostarlimab and niraparib in primary advanced ovarian cancerA-C Hardy-Bessard, E Pujade-Lauraine, R G Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2024
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trialP Harter, C Marth, M-A Mouret-Reynier, et al.
ESMO Open|June 10, 2025
Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancerS Nag, I Ray Coquard, S Gupta, et al.
Gynecologic Oncology|July 7, 2020
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG networkF Derquin, A Floquet, A C Hardy-Bessard, et al.
ESMO Open|November 3, 2023
Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAFV600-mutated melanomaJ Y Blay, C Cropet, S Mansard, et al.
Pageof 32